4//SEC Filing
WYETH 4
Accession 0001209191-09-049106
CIK 0000005187operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:23 PM ET
Size
25.7 KB
Accession
0001209191-09-049106
Insider Transaction Report
Form 4
WYETHWYE
Peppard Denise M.
Sr. VP Human Resources
Transactions
- Disposition to Issuer
Common Stock
2009-10-15$49.58/sh−18,220$903,348→ 12,526 total - Disposition to Issuer
Employee Stock Option
2009-10-15−20,000→ 0 totalExercise: $56.52→ Common Stock (20,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$6.01/sh−8,597$51,668→ 0 totalExercise: $43.57→ Common Stock (8,597 underlying) - Disposition to Issuer
Common Stock
2009-10-15−12,526→ 0 total - Disposition to Issuer
Employee Stock Option
2009-10-15−30,000→ 0 totalExercise: $60.70→ Common Stock (30,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$1.36/sh−17,194$23,384→ 0 totalExercise: $48.22→ Common Stock (17,194 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$5.02/sh−52,000$261,040→ 0 totalExercise: $44.56→ Common Stock (52,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15−7,100→ 0 totalExercise: $56.59→ Common Stock (7,100 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$14.90/sh−1$15→ 0 totalExercise: $34.67→ Common Stock (1 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15−25,790→ 0 totalExercise: $56.00→ Common Stock (25,790 underlying)
Footnotes (5)
- [F1]Represents restricted stock units.
- [F2]Pursuant to the Agreement and Plan of Merger by and among Wyeth, Pfizer Inc. and Wagner Acquisition Corp., dated as of January 25, 2009 (as amended, the "Merger Agreement"), each restricted stock unit was cancelled at the effective time of the merger in exchange for cash equal to the per share value of the merger consideration of $49.58, less any applicable tax withholding.
- [F3]Represents Wyeth common stock.
- [F4]Pursuant to the Merger Agreement, each of these shares was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock, less any applicable tax withholding.
- [F5]Pursuant to the Merger Agreement, each outstanding and unexercised option, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying such option and (b) the excess, if any, of the per share value of the merger consideration of $49.58 over the per share exercise price of the option, less any applicable tax withholding.
Documents
Issuer
WYETH
CIK 0000005187
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000005187
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:23 PM ET
- Size
- 25.7 KB